Shares of Moderna Inc.
sank 0.83% to $168.10 Thursday, on what proved to be an all-around grim buying and selling session for the inventory market, with the NASDAQ Composite Index
falling 0.94% to 13,818.41 and Dow Jones Industrial Common
falling 0.94% to 33,815.90. Moderna Inc. closed $21.16 beneath its 52-week excessive ($189.26), which the corporate reached on February eighth.
The inventory demonstrated a blended efficiency when in comparison with a few of its opponents Thursday, as AbbVie Inc.
fell 0.68% to $110.05, Amgen Inc.
fell 1.44% to $255.05, and AstraZeneca PLC ADR
fell 0.75% to $52.71. Buying and selling quantity (15.9 M) eclipsed its 50-day common quantity of 8.9 M.